Constitutive activation of Stat3 in human prostate tumors and cell lines: Direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells

Cancer Research

Volumn 62, Issue 22, 2002, Pages 6659-6666

  Mora, Linda B ^a   Buettner, Ralf ^a   Seigne, John ^a   Diaz, Jose ^a   Ahmad, Nazeel ^a   Garcia, Roy ^a   Bowman, Tammy ^a   Falcone, Robert ^a   Fairclough, Rita ^a   Cantor, Alan ^a   Muro Cacho, Carlos ^a   Livingston, Sandy ^a   Karras, James ^b   Pow Sang, Julio ^a   Jove, Richard ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; STAT PROTEIN; STAT3 PROTEIN;

APOPTOSIS; ARTICLE; BINDING ASSAY; CANCER CELL; CANCER CELL CULTURE; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; DNA BINDING; GENE ACTIVITY; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE TUMOR; PROSTATECTOMY; PROTEIN FAMILY; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION TERMINATION; TUMOR CELL LINE;

3T3 CELLS; ANIMALS; APOPTOSIS; CELL DIVISION; CELL SURVIVAL; DNA, NEOPLASM; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0037112367     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Bostwick, D. G., and Foster, C. S. Predictive factors in prostate cancer: current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer. Semin. Urol. Oncol., 17: 222-272, 1999
2. Partin, A. W., Murphy, G. P., and Brawer, M. K. Report on Prostate Cancer Tumor Marker Workshop 1999. Cancer (Phila.), 88: 955-963, 2000
3. Banerjee, M., Biswas, D., Sakr, W., and Wood, D. P. J. Recursive partitioning for prognostic grouping of patients with clinically localized prostate carcinoma. Cancer (Phila.), 89: 404-411, 2000
4. Di Paola, R. S., Kumar, P., Hait, W. N., and Weiss, R. E. State-of-the-art prostate cancer treatment and research. A report from the Cancer Institute of New Jersey. J. Med., 98: 23-33, 2001
5. Diaz, J. I., Mora, L. B., Austin, P. F., Muro-Cacho, C. A., Cantor, A. B., Nicosia, S. V., and Pow-Sang, J. M. Predictability of PSA failure in prostate cancer by computerized cytometric assessment of tumoral cell proliferation. Urology, 53: 931-938, 1999
6. Darnell, J. E., Kerr, I. M., and Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (Wash. DC), 264: 1415-1421, 1994
7. Darnell, J. E. STATs and gene regulation. Science (Wash. DC), 277: 1630-1635, 1997
8. Bromberg, J., and Darnell, J. E. The role of STATs in transcriptional control and their impact on cellular function. Oncogene. 19: 2468-2473, 2000
9. Wurster, A. L., Tanaka, T., and Grusby, M. J. The biology of Stat4 and Stat6. Oncogene, 19: 2577-2584, 2000
10. Herrington, J., Smit, L. S., Schwartz, J., and Carter-Su, C. The role of STAT proteins in growth hormone signaling. Oncogene, 19: 2585-2597, 2000
11. Akira, S. Roles of STAT3 defined by tissue-specific gene targeting. Oncogene, 19: 2607-2611, 2000
12. Smithgall, T. E., Briggs, S. D., Schreiner, S., Lerner, E. C., Cheng, H., and Wilson, M. B. Control of myeloid differentiation and survival by Stats. Oncogene, 19: 2612-2618, 2000
13. Heinrich, P. C., Behrmann, I., Muller-Newen, G., Schaper, F., and Graeve, L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J., 334: 297-314, 1998
14. Hirano, T., Ishihara, K., and Hibi, M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene, 19: 2548-2556, 2000
15. Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernandez-Luna, J. L., Nuñez, G., Dalton, W. S., and Jove, R. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity, 10: 105-115, 1999
16. Smith, P. C., Hobish, A., Lin, D. L., Culig, Z., and Keller, E. T. Interleukin-6 and prostate cancer progression. Cytokine Growth Factor Rev., 12: 33-40, 2001
17. Yu, C. L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., and Jove, R. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science (Wash. DC), 269: 81-83, 1995
18. Cao, X., Tay, A., Guy, G. R., and Tan, Y. H. Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol. Cell. Biol., 16: 1595-1603, 1996
19. Chaturvedi, P., Sharma, S., and Reddy, E. P. Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs. Mol. Cell. Biol., 17: 3295-3304, 1997
20. Garcia, R., Yu, C. L., Hudnall, A, Catlett, R., Nelson, K. L., Smithgall, T., Fujita, D. J., Ethier, S. P., and Jove, R. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Diff., 8: 1267-1276, 1997
21. Bromberg, J. F., Horvath, C. M., Besser, D., Lathem, W. W., and Darnell, J. E. Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol., 18: 2553-2558, 1998
22. Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R. P., and Jove, R. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol., 18: 2545-2552, 1998
23. Bowman, T., Broome, M. A., Sinibaldi, D., Wharton, W., Pledger, W. J., Sedivy, J. M., Irby, R., Yeatman, T., Courtneidge, S. A., and Jove, R. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc. Natl. Acad. Sci. USA, 98: 7319-7324, 2001
24. Bowman, T., Garcia, R., Turkson, J., and Jove, R. STATs in oncogenesis. Oncogene, 19: 2474-2488, 2000
25. Song, J. I., and Grandis, J. R. STAT signaling in head and neck cancer. Oncogene, 19: 2489-2495, 2000
26. Lin, T. S., Mahajan, S., and Frank, D. A. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene, 19: 2566-2576, 2000
27. Coffer, P. J., Koenderman, L., and de Groot, R. P. The role of STATs in myeloid differentiation and leukemia. Oncogene, 19: 2511-2522, 2000
28. Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., and Darnell, J. E., Jr. Stat3 as an oncogene. Cell, 98: 295-303, 1999
29. Karras, J. G., McKay, R. A., Lu, T., Pych, J., Frank, D. A., Rothstein, T. L., and Monia, B. STAT3 regulates the growth and immunoglobulin production of BCL(1) B cell lymphoma through control of cell cycle progression. Cell. Immunol., 202: 124-135, 2000
30. Ni, Z., Lou, W., Leman, E. S., and Gao, A. C. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells. Cancer Res., 60: 1225-1228, 2000
31. Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., and Tweardy, D. J. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J. Clin. Investig., 102: 1385-1392, 1998
32. Siegall, C. B., Schwab, G., Nordan, R. P., FitzGerald, D. J., and Pastan, I. Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res., 50: 7786-7788, 1990
33. Okamoto, M., Lee, C., and Oyasu, R. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res., 57: 141-146, 1997
34. Hobisch, A., Eder, I. E., Putz, T., Horninger, W., Bartsch, G., Klocker, H., and Culig, Z. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res., 58: 4640-4645, 1998
35. Drachenberg, D. E., Elgamal, A. A., Rowbotham, R., Peterson, M., and Murphy, G. P. Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate, 41: 127-133, 1999
36. Adler, H. L., McCurdy, M. A., Kattan, M. W., Timme, T. L., Scardino, P. T., and Thompson, T. C. Elevated levels of circulating interleukin-6 and transforming growth factor-β1 in patients with metastatic prostatic carcinoma. J. Urol., 161: 182-187, 1999
37. Lou, W., Ni, Z., Dyer, K., Tweardy, D. J., and Gao, A. C. Interleukin-6 induces prostate cancer cell growth accompanied by activation of Stat3 signaling pathway. Prostate, 42: 239-242, 2000
38. Spiotto, M. T., and Chung, T. D. STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP. Prostate, 42: 88-98, 2000
39. Spiotto, M. T., and Chung, T. D. STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells. Prostate, 42: 186-195, 2000
40. Chung, T. D. K., Yu, J. J., Spiotto, M. T., Bartkowski, M., and Simons, J. W. Characterization of the role of IL-6 in the progression of prostate cancer. Prostate, 38: 199-207, 1999
41. Chen, T., Wang, L. H., and Farrar, W. L. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. Cancer Res., 60: 2132-2135, 2000
42. Campbell, C. L., Jiang, Z., Savarese, M. F., and Savarese, T. M. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma. Am. J. Pathol., 158: 25-32, 2001
43. Garcia, R., Sun, J., Bowman, T. L., Niu, G., Zhang, Y., Minton, S., Muro-Cacho, C., Ku, N. N., Falcone, R., Cox, C., Kraker, A., Levitzki, A., Parsons, S., Sebti, S. M., and, and Jove, R. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene, 20: 2499-2513, 2001
44. Niu, G., Bowman, T., Huang, M., Shivers, S., Reintgen, D., Daud, A., Chang, A., Kraker, A., Jove, R., and Yu, H. Roles of activated Src and Stat3 signaling in melanoma tumor growth. Oncogene, 21: 7001-7010, 2002
45. Grandis, J. R., Drenning, S. D., Zeng, Q., Watkins, S. C., Melhem, M. F., Endo, S., Johnson, D. E., Huang, L., He, Y., and Kim, J. D. Constitutive activation of Stat3 signaling abrogrates apoptosis in squamous cell carcinogenesis in vivo. Proc. Natl. Acad. Sci. USA, 97: 4227-4232, 2000
46. Turkson, J., and Jove, R. STAT proteins: Novel molecular targets for cancer drug discovery. Oncogene, 19: 6613-6626, 2000